Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Other neoplasm 1 Other hematologic neoplasm 1 Gynecologic 1 Breast 1

Conditions

Interventions

Biopsy 8 Polymerase Chain Reaction 6 Peripheral Blood Stem Cell Transplantation 5 Epoetin Alfa 5 Surveys and Questionnaires 4 Sulindac 4 Microarray Analysis 4 Gene Expression Profiling 4 Early Intervention, Educational 4 Cyclophosphamide 4 Colposcopy 4 Cisplatin 4 Cetuximab 4 Celecoxib 4 fludarabine phosphate 3 Vaginal Smears 3 Selenium 3 Pemetrexed 3 Methotrexate 3 Imiquimod 3 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3 Eflornithine 3 Darbepoetin alfa 3 Aspirin 3 Antilymphocyte Serum 3 Whole-Body Irradiation 2 Vitamin E 2 Videotape Recording 2 Tacrolimus 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Psychotherapy × Other neoplasm × Clear all

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡